-+ 0.00%
-+ 0.00%
-+ 0.00%
ABL Diagnostics calls Sept. 17 shareholder vote on Euronext Paris to Euronext Growth listing shift
Share
Listen to the news
ABL Diagnostics calls Sept. 17 shareholder vote on Euronext Paris to Euronext Growth listing shift
  • ABL Diagnostics set a Sept. 17, 2026 shareholder meeting to vote on moving its share listing from Euronext Paris to Euronext Growth Paris.
  • The agenda also includes a vote on changing the company’s corporate name.
  • Meeting scheduled for 11:00 a.m. in Paris.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ABL Diagnostics SA published the original content used to generate this news brief via Business Wire (Ref. ID: 202608271200BIZWIRE_USPR_____20260827_BW338908) on August 27, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending